SPECTRUM PHARMACEUTICALS INC Business Combination, Liabilities Arising from Contingencies, Amount Recognized
SPECTRUM PHARMACEUTICALS INC had Business Combination, Liabilities Arising from Contingencies, Amount Recognized of $4.34 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized · last filed 2019-02-28
- 2018-12-31: Business Combination, Liabilities Arising from Contingencies, Amount Recognized $4.34M.
- 2018-09-30: Business Combination, Liabilities Arising from Contingencies, Amount Recognized $5.55M.
- 2018-06-30: Business Combination, Liabilities Arising from Contingencies, Amount Recognized $6.75M.
- 2018-03-31: Business Combination, Liabilities Arising from Contingencies, Amount Recognized $6.56M.
| Period end | Business Combination, Liabilities Arising from Contingencies, Amount Recognized |
|---|---|
| 2018-12-31 | $4.34M 10-K · filed 2019-02-28 |
| 2018-09-30 | $5.55M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.75M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.56M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $6.27M 10-K · filed 2019-02-28 |
| 2017-09-30 | $4.55M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $1.61M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $1.51M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.31M 10-K · filed 2018-03-07 |
| 2016-09-30 | $1.92M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.99M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.71M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $1.44M 10-K · filed 2017-03-14 |
| 2015-09-30 | $2.53M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $2.75M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $2.75M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $2.44M 10-K · filed 2016-03-14 |
| 2014-09-30 | $10.24M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $10.06M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $9.05M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $8.33M 10-K · filed 2015-03-13 |